Poster Presentations Session I
Poster Presentations Session I Saturday, 16 September 2017
POSTERS SET-UP: 8:15 - 8:30
POSTERS DISPLAY HOURS: 8:30 - 20:00
POSTER AUTHOR DISCUSSION: 18:30 - 19:30
POSTERS DISMANTLE: 20:00


Poster display locations are shown below the poster codes
RESPIRATORY-RELATED DISORDERS - Clinical Outcomes Studies
PRS1
J4
EFFECT OF HESPERIDIN IN BLEOMYCIN-INDUCED PULMONARY FIBROSIS IN RATS: CRITICAL ROLE OF NRF-2, TNF-Α, AND IL-1Β
Kandhare AD, Mukherjee A, Bodhankar SL
Poona College of Pharmacy, Bharati Vidyapeeth Deemed University, Pune, Maharashtra, India

PRS2
J5
DRUG-SAFETY PROGRAM IMPACT IN HOSPITALIZATION PERSISTENT SEVERE ASTHMA PATIENTS.
Estrada JI1, Restrepo AM1, Giraldo PA1, Abad JM2, Serna JA1, Segura AM3
1+helPharma IPS, Medellin, Colombia, 2SURA EPS, Medellin, Colombia, 3CES University, Medellin, Colombia

PRS3
J6
DRUG-SAFETY PROGRAM IMPACT IN THE EMERGENCY FREQUENCY AT PATIENTS WITH PERSISTENT SEVERE ASTHMA.
Estrada JI1, Restrepo AM1, Giraldo PA1, Serna JA1, Abad JM2, Segura AM3
1+helPharma IPS, Medellin, Colombia, 2SURA EPS, Medellin, Colombia, 3CES University, Medellin, Colombia

PRS4
WITHDRAWN

RESPIRATORY-RELATED DISORDERS - Cost Studies
PRS5
J7
ESTIMATING THE FINANCIAL IMPACT OF INTRODUCING GLYCOPYRRONIUM BROMIDE IN THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) FROM THE PERSPECTIVE OF PUBLIC PAYER OF SÃO PAULO (SP) – BRAZIL.
Suzuki C, Lopes N
Novartis Biociências SA, Sao Paulo, Brazil

PRS6
J8
WITHDRAWN

PRS7
J9
QUALITY OF LIFE AND ECONOMIC BURDEN AMONG CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) PATIENTS IN JAPAN
Kubota K1, Igarashi A2, Saito Y3, Oyamada M4, Miyata T4
1Yokohama City University, Yokohama, Japan, 2University of Tokyo, Tokyo, Japan, 3Kyoto University School of Public Health, Kyoto, Japan, 4Health and Global Policy Institute, Tokyo, Japan

PRS8
J10
ANÁLISE DE CUSTO-EFETIVIDADE DO TRATAMENTO DIRETAMENTE OBSERVADO DA TUBERCULOSE
Gomes MP1, Nunes AA2, Sarti FM3, Ruffino Netto A1
1Faculdade de Medicina de Ribeirão Preto, Ribeirão Preto, Brazil, 2University of São Paulo, Ribeirão Preto, Brazil, 3University od São Paulo, São Paulo, Brazil

PRS9
J11
ANÁLISIS DE COSTO EFECTIVIDAD DEL USO DE BUDESONIDA/FORMOTEROL FRENTE A SALMETEROL/FLUTICASONA, EN PACIENTES CON ASMA MODERADA Y SEVERA EN COLOMBIA
Romero Prada ME, Roa Cardenas NC, Huerfano LM
Salutia Foundation - Research center in economy, management and health technologies., Bogota, Colombia

PRS10
J12
COST-UTILITY OF THE FIXED COMBINATION OF INDACATEROL/GLYCOPYRONIUM VS. SALMETEROL/FLUTICASONE AND TIOTROPIUM IN THE MANAGEMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN COLOMBIA
Patino A1, Londoño D2, Karpf E1
1Novartis Colombia, Bogota, Colombia, 2Fundacion Santa Fe de Bogota, Bogota, Colombia

RESPIRATORY-RELATED DISORDERS - Patient-Reported Outcomes & Patient Preference Studies
PRS11
J13
DRUG-SAFETY PROGRAM IMPACT AT HEALTH RELATED QUALITY OF LIFE AT PATIENTS DIAGNOSED WITH PERSISTENT SEVERE ASTHMA.
Estrada JI1, Restrepo AM1, Giraldo PA1, Abad JM2, Serna JA1, Segura AM3
1+helPharma IPS, Medellin, Colombia, 2SURA EPS, Medellin, Colombia, 3CES University, Medellin, Colombia

PRS12
J14
DRUG-SAFETY PROGRAM IMPACT AT HEALTH CARE PERCEPTION AT PATIENTS DIAGNOSED WITH PERSISTENT SEVERE ASTHMA.
Estrada JI1, Restrepo AM1, Giraldo PA1, Serna JA1, Abad JM2, Segura AM3
1+helPharma IPS, Medellin, Colombia, 2SURA EPS, Medellin, Colombia, 3CES University, Medellin, Colombia

PRS13
J15
AVALIAÇÃO DA QUALIDADE DE VIDA EM CRIANÇAS E ADOLESCENTES COM ASMA
Almeida A1, Figueiredo C2, Rodrigues C3
1Universidade da Beira Interior, COVILHA, Portugal, 2Universidade da Beira Interior, Covilhã, Portugal, 3Centro Hospitalar Cova da Beira, Covilhã3, Portugal

Contact ISPOR @ info@ispor.org | View Legal Disclaimer
© 2018 International Society for Pharmacoeconomics and Outcomes Research.
All rights reserved under International and Pan-American Copyright Conventions.